Harricharran, Trisheena
Ogunwobi, Olorunseun O. http://orcid.org/0000-0003-3388-2137
Funding for this research was provided by:
National Cancer Institute, National Institutes of Health, USA (1 U54 CA221704-01A1)
Article History
Accepted: 29 May 2019
First Online: 14 June 2019
Compliance with Ethical Standards
:
: Olorunseun O. Ogunwobi is a Co-Founder of NucleoBio, Inc., a City University of New York start-up biotechnology company. There are no other conflicts of interest relevant to this article.
: The analysis was performed using publicly available de-identified data from The Cancer Genome Atlas. Ethical approval was unnecessary for this analysis.
: There was no interaction with human subjects or identifiable human subject information. Hence, informed consent was unnecessary for this analysis.